Washington, D.C.: The American Academy of HIV Medicine (AAHIVM) welcomes Congress’s final approval of the fiscal year (FY) 2026 State, Foreign Operations, and Related Programs (SFOPS) appropriations bill and recognizes the bipartisan effort required to advance the legislation amid a constrained fiscal and political environment. “In...
As Congress moves toward final action on the Fiscal Year 2026 (FY26) consolidated appropriations bill, the American Academy of HIV Medicine (AAHIVM) sees a mixed picture for domestic HIV programs. While the bill steps back from some of the most damaging cuts proposed last year...
AI/ML–driven prediction of HIV treatment outcomes and care retention using clinical and social determinants data WASHINGTON, DC: The American Academy of HIV Medicine and the Institute for Technology in Health Care have awarded the 2025 Cesar Augusto Caceres Award for Innovations in HIV Prevention and Care...
Washington, DC (December 1, 2025) – A statement from Bruce J. Packet, II, the Executive Director of the American Academy of HIV Medicine: “Today, World AIDS Day, is a moment to honor those we’ve lost, uplift the communities still fighting, and reaffirm the commitment needed to...
WASHINGTON, DC (December 1, 2025): The American Pharmacists Association (APhA) and the American Academy of HIV Medicine (AAHIVM) today announce that AAHIVM has formally endorsed the clinical and educational content of APhA’s Pharmacy-Based HIV Prevention Services Certificate Training Program and Microcredential. The endorsement follows a...
WASHINGTON, DC: The American Academy of HIV Medicine welcomes the second class of the Dr. Dawn K. Smith HIV Prevention Clinical Fellowship. These Fellows demonstrate the passion and dedication to HIV prevention for which Dr. Smith was well-known. The 2025 class includes: Jaimee K. Colvin, MSN, APRN,...